Mitochondrion-Dependent Cell Death in TDP-43 Proteinopathies.
Chantal B LuciniRalf J BraunPublished in: Biomedicines (2021)
In the last decade, pieces of evidence for TDP-43-mediated mitochondrial dysfunction in neurodegenerative diseases have accumulated. In patient samples, in vitro and in vivo models have shown mitochondrial accumulation of TDP-43, concomitantly with hallmarks of mitochondrial destabilization, such as increased production of reactive oxygen species (ROS), reduced level of oxidative phosphorylation (OXPHOS), and mitochondrial membrane permeabilization. Incidences of TDP-43-dependent cell death, which depends on mitochondrial DNA (mtDNA) content, is increased upon ageing. However, the molecular pathways behind mitochondrion-dependent cell death in TDP-43 proteinopathies remained unclear. In this review, we discuss the role of TDP-43 in mitochondria, as well as in mitochondrion-dependent cell death. This review includes the recent discovery of the TDP-43-dependent activation of the innate immunity cyclic GMP-AMP synthase/stimulator of interferon genes (cGAS/STING) pathway. Unravelling cell death mechanisms upon TDP-43 accumulation in mitochondria may open up new opportunities in TDP-43 proteinopathy research.
Keyphrases
- cell death
- amyotrophic lateral sclerosis
- mitochondrial dna
- cell cycle arrest
- reactive oxygen species
- oxidative stress
- small molecule
- case report
- high throughput
- gene expression
- dna methylation
- cystic fibrosis
- dendritic cells
- cell proliferation
- transcription factor
- immune response
- escherichia coli
- genome wide
- dna damage
- minimally invasive